AAAAAA

   
Results: 1-8 |
Results: 8
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401
Authors: Gerber, JG Rosenkranz, S Segal, Y Aberg, J D'Amico, R Mildvan, D Gulick, R Hughes, V Flexner, C Aweeka, F Hsu, A Gal, J
Citation: Jg. Gerber et al., Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401, J ACQ IMM D, 27(2), 2001, pp. 153-160
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus
Authors: Becker, S Fisher, A Flexner, C Gerber, JG Haubrich, R Kashuba, ADM Luber, AD Piscitelli, SC
Citation: S. Becker et al., Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus, J ACQ IMM D, 27(2), 2001, pp. 210-211
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir- experienced subjects: AIDS Clinical Trials Group protocol 373
Authors: Gulick, RM Smeaton, LM D'Aquila, RT Eron, JJ Currier, JS Gerber, JG Acosta, E Sommadossi, JP Tung, R Snyder, S Kuritzkes, DR Murphy, RL
Citation: Rm. Gulick et al., Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir- experienced subjects: AIDS Clinical Trials Group protocol 373, J INFEC DIS, 183(5), 2001, pp. 715-721
Using pharmacokinetics to optimize antiretroviral drug-drug interactions the treatment of human immunodeficiency virus infection
Authors: Gerber, JG
Citation: Jg. Gerber, Using pharmacokinetics to optimize antiretroviral drug-drug interactions the treatment of human immunodeficiency virus infection, CLIN INF D, 30, 2000, pp. S123-S129
Lack of an effect of age on beta-adrenoceptor-mediated lipolysis in isolated human adipocytes
Authors: Gerber, JG Detmar-Hanna, D Zahniser, NR
Citation: Jg. Gerber et al., Lack of an effect of age on beta-adrenoceptor-mediated lipolysis in isolated human adipocytes, J GERONT A, 54(2), 1999, pp. B71-B77
The effect of increasing alpha(1)-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors
Authors: Zhang, XQ Schooley, RT Gerber, JG
Citation: Xq. Zhang et al., The effect of increasing alpha(1)-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors, J INFEC DIS, 180(6), 1999, pp. 1833-1837
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection
Authors: Murphy, RL Gulick, RM DeGruttola, V D'Aquila, RT Eron, JJ Sommadossi, JP Currier, JS Smeaton, L Frank, I Caliendo, AM Gerber, JG Tung, R Kuritzkes, DR
Citation: Rl. Murphy et al., Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection, J INFEC DIS, 179(4), 1999, pp. 808-816
Neither dapsone hydroxylation nor cortisol 6 beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors
Authors: Gass, RJA Gal, J Fogle, PW Detmar-Hanna, D Gerber, JG
Citation: Rja. Gass et al., Neither dapsone hydroxylation nor cortisol 6 beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors, EUR J CL PH, 54(9-10), 1998, pp. 741-747
Risultati: 1-8 |